Exhibit 99.1 Interpace Biosciences Announces Second Quarter 2025 Financial and Business Results PARSIPPANY, NJ, Aug 7, 2025 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX: IDXG) today announced financial results for the second quarter ended June 30, 2025 and provided a business and financial update. Second quarter Net Revenue was $9.2 million. Loss from continuing operations in the second quarter of 2025 was$0.5 million. "The Company achieved record Thyroid test volume ...